ABSTRACT Cystic fibrosis has been reported to be associated with an increased prevalence of atopy and reversible airways obstruction. 
FEV, or PEFR or both increased by 15% or more in nine of the 23 patients after inhalation of fenoterol, the mean increases in FEV,, FVC, and PEFR for the whole group being 9 5%, 11%, and 16*9%. These results indicate that while bronchiectasis provokes a hyperimmune response it differs from cystic fibrosis in that there is no significant increase in the prevalence of atopy. The finding of reversible airways obstruction, however, suggests that bronchodilators may be useful adjuncts to treatment.
An increased prevalence of atopy and reversible airways obstruction has been reported in patients with cystic fibrosis' -4 but its significance is unclear. Some authors suggest that atopy is genetically an intrinsic part of the cystic fibrosis syndrome, while others propose that it is a consequence of prolonged, excessive stimulation of the immune system by chronic infection. To test the hypothesis that chronic infection per se predisposes to atopy, we studied patients with bronchiectasis, a condition where pulmonary pathological changes are in many respects similar to those of cystic fibrosis.
Previous studies of atopy in bronchiectasis have been few and have produced contradictory results. Varpela et al,S in an uncontrolled study, reported an increased prevalence of atopy; while Hilton and Doyle,6 using diseased controls, and Nogrady et al, ' in another uncontrolled study, failed to confirm this. We In the patients the mean daily sputum volume at the time of the study was 60 ml and, although all had purulent sputum, organisms were cultured in only 10 cases (43%). Haemophilus infiuenzae was the commonest pathogen, being found in eight of the 10 culture positive patients, while pneumococci were found in two and Pseudomonas aeruginosa in one. The extent of the disease on bronchography varied from a single lobe affected in four patients to all five lobes in two, the mean being 2-8 diseased lobes per patient. Eleven patients were taking prophylactic antibiotics and five, known to have reversible airways obstruction, took inhaled or oral bronchodilators. Three of the five were having inhaled corticosteroid treatment and two with severe wheeze were taking prednisolone 5 mg daily.
ATOPIC INDICES
There was no significant difference between patients and controls in the prevalence of atopic symptoms (12 and 10 respectively) or in the prevalence of family atopy (12 and 11) . Individual atopic symptoms, with the exception of wheeze (five patients but no control), occurred with the same frequency in both groups (table 1) .
Responses to skinprick tests were positive in seven patients and six controls but patients with positive results had significantly more reactions (mean 5-4) than controls with positive results (mean 2.6; p < 0.05). Patients with positive responses also had a larger mean weal diameter (5.3 mm) than controls with positive responses (3.9 mm) (p < 0-01). Table 2 illustrates the prevalence of positive reactions in each group. Three patients, but no control, reacted to non-specific composite mould extracts; two of these also reacted to A fumigatus. These (fig 1) . In none of the infiuenzae infection, or prophylactic antibiotic subclasses was serum concentration correlated with To exclude the possibility that the prevalence of atopic indices and immunoglobin concentrations in the group of patients were modified by the use of steroids in a subgroup, the data on the 18 untreated patients and their matched controls were reanalysed separately. Again, there was no significant differ- 
